YR

Yamesh Rajendra Sable

Active Director Director DIN 10455572
DIN 10455572 First appointment Jan 2024
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value •••• Premium profile

About Yamesh Rajendra Sable

Data last updated:

Yamesh Rajendra Sable is a Director at Treatoogram Private Limited (since 2024). Treatoogram Private Limited reported revenue of ₹9.1 Lakh (FY 2025).

DIN 10455572
Primary Designation Director
First Appointment 06 Jan 2024
Oldest Company Age 2 yrs
Largest company Treatoogram Private Limited · ₹9.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Treatoogram Private Limited U46596MH2024PTC416830
Director06 Jan 20242024₹9.1 Lakh (FY 2025)Active

Board colleagues of Yamesh Rajendra Sable

NameDINCompanyDesignation
Sheela Rajendra Sable10455573Treatoogram Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Treatoogram Private Limited
Premium access

Shareholding and investment profile for Yamesh Rajendra Sable

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yamesh Rajendra Sable

Yamesh Rajendra Sable currently holds 1 directorship: Treatoogram Private Limited (Director, since 06 Jan 2024, revenue ₹9.1 Lakh (FY 2025)).

Yamesh Rajendra Sable was first appointed on 06 Jan 2024 as Director at Treatoogram Private Limited.

The current boards of Yamesh Rajendra Sable's companies include Sheela Rajendra Sable (Treatoogram Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available